ARCHIVES

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions

September 27, 1996

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

In Brief: Cancer Control To Push Environmental Research Occupational Hazards; Bailer to Journal Post

May 24, 1974

Obama Reiterates Support For Doubling Budgets For Cancer Research, Other Science Agencies

May 1, 2009

Cancer Letter Closes Out 1983, 10th Year

December 16, 1983

Children’s Memorial Hospital Receives $3 Million Endowment From Price Trust

May 28, 2010